Development of modified release diltiazem HCL tablets using composite index to identify optimal formulation

Drug Development and Industrial Pharmacy

Volumn 29, Issue 5, 2003, Pages 565-574

  Gohel, M C ^a   Patel, M M ^b   Amin, A F ^b  

^a L M COLLEGE OF PHARMACY   (India)

^b GANPAT UNIVERSITY   (India)

Author keywords

Composite index; Factorial design; Modified guar gum; Modified ispaghula husk powder; Tartaric acid

Indexed keywords

CALCIUM PHOSPHATE DIBASIC; DILTIAZEM; GUAR GUM; ISPAGULA; TARTARIC ACID; WATER;

ARTICLE; CALCULATION; DRUG DESIGN; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; PH; REACTION ANALYSIS; STOMACH JUICE; TABLET;

COMPRESSIVE STRENGTH; DELAYED-ACTION PREPARATIONS; DILTIAZEM; DRUG CARRIERS; DRUG COMPOUNDING; GALACTANS; GELS; KINETICS; MANNANS; MODELS, CHEMICAL; PLANT GUMS; POWDERS; PSYLLIUM; SOLUBILITY; TABLETS; TARTRATES; TIME FACTORS;

EID: 0037570797     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.1081/DDC-120018645     Document Type: Article

References (24)

1. Jain, N.K.; Kulkarni, K.; Talwar, N. Controlled release tablet formulation of isoniazid. Pharmazie 1992, 47 (4), 277-278.
2. Gohel, M.C.; Jani, G.K.; Patel, N.K.; Gondaliya, D.P. Optimisation of hydrophilic matrix tablet formulation of diclofenac sodium using a mixture design. Pharm. Pharmacol. Comm. 1998, 4 (9), 433-438.
3. Gohel, M.C.; Patel, K.V. Formulation optimisation of diltiazem-HCl matrix tablets containing modified ispaghula husk using factorial design. Drug Dev. Ind. Pharm. 1997, 23 (11), 1055-1061.
4. Gohel, M.C.; Amin, A.F.; Chhabaria, M.T.; Panchal, M.K.; Lalwani, Anita. Modulation of drug release rate of diltiazem-HCl from hydrogel matrices of succinic acid-treated ispaghula husk. Pharm. Dev. Technol. 2000, 5 (3), 375-381.
5. Khullar, P.; Khar, R.K.; Agrawal, S.P. Evaluation of hydrogel-based controlled-release niacin tablets. Drug Dev. Ind. Pharm. 1998, 24 (5), 479-483.
6. Kuhrts, E.H.; Friend, D.R.; Parasrampuria, K.Yu.J. Sustained release drug delivery employing a powdered hydrocolloid gum obtainable from higher plants. PCT Int. Appl. WO96 1996, 16, 638.
7. Bhalla, H.L.; Shah, A.A. Controlled release matrices for ketoprofen. Indian Drugs 1991, 28 (9), 420-422.
8. Jain, N.K.; Kulkarni, K.; Talwar, N. Controlled-release tablet formulation of isoniazid. Pharmazie 1992, 47 (4), 277-278.
9. Misra, A.N.; Baweja, J.M. Modified guar gum as hydrophilic matrix for controlled release tablets. Indian Drugs 1997, 34 (4), 216-223.
10. Gohel, M.C.; Amin, A.F.; Panchal, M.K.; Momin, M.; Bajaj, S.; Lalwani, A. Preliminary investigation in matrix based tablet formulation of diclofenac sodium containing succinic acid treated guar gum. Boll. Chim. Farm. 1998, 137 (6), 198-203.
11. Khan, M.Z.I. Recent trends and progress in sustained or controlled oral delivery of some water-soluble drugs: morphine salts, diltiazem and captopril. Drug Dev. Ind. Pharm. 1995, 21 (9), 1037-1070.
12. Venkatesh, G.M. Development of controlled release SK & F 82526-J, buffer bead formulations with tartaric acid as a buffer. Pharm. Dev. Technol. 1998, 3, 477-485.
13. Gabr, K.E. Effect of organic acids on the release patterns of weakly basic drugs from inert sustained release matrix tablets. Eur. J. Pharm. Biopharm. 1992, 38, 199-202.
14. Gohel, M.C.; Patel, M.M. Release rate modulation of diltiazem HCl from hydrophilic matrix of tartaric acid treated guar gum. Int. J. Pharm. Excipients 2001, 3 (2), 39-45.
15. Salsa, T.; Veiga, F.; Pina, M.E. Drug Dev. Ind. Pharm. 1997, 23 (9), 929-938.
16. 2. Pharm. Res. 1998, 15 (6), 889-896.
17. Derringer, G.; Suich, R.; Simultaneous optimization of several response variables. Journal of Quality Technology 1980, 12 (4), 214-219.
18. Bodea, A.; Leucuta, S.E. Drug Dev. Ind. Pharm. 1998, 24 (2), 145-155.
19. Robert Lu, D.; Abu-Izza, K.; Chen, W. Pharm. Tech. 1996, 1 (4), 405-414.
20. Wang, Y. Min.; Sato, H.; Adachi, I.; Horikoshi, I. J. Pharm. Sci. 1996, 85 (11), 1204-1210.
21. Shigeo, O.; Toshihiko, K.; Yousuke, M.; Masaharn, M.; Hiroshima, S.; Kozo, T.; Nagai, T. J. Pharm. Sci. 1994, 83 (3), 439-443.
22. Taylor, M.; Ginsburg, J.; Hickey, A.; Gheyas, F. Composite method to quantify powder flow as a screening method in early tablet or capsule formulation development. Pharm. Sci. Tech. 2000, 1 (3), 18.
23. Bamba, M.; Puisieusx, F. Int. J. Pharm. 1979, 2, 307-315.
24. Peck, G.E.; Johnson, A.D.; Aderson, V.L. A statistical approach for the development of an oral controlled-release matrix tablets. Pharm. Res. 1990, 7, 1092-1097.